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Abstract 
 
Background: Tracheostomy is a deliberate surgical procedure performed to make an opening in the anterior wall of the 
trachea and maintaining this opening with the use of a tracheostomy tube. Colonization of the tracheobronchial tree with 
microorganisms almost always follows tracheal intubation, tracheostomy, or the use of ventilatory tubes. Infection of the 
tracheostomy wound site frequently occurs after prolonged use of the tracheostomy. Objective of the study was to 
establish the bacteria colonizing the lower respiratory tract in tracheotomized patients. Materials & Methods: We 
collected 36 endotracheal tube samples very aseptically. The collected specimen was kept in a sterile container and was 
sent immediately to microbiology department for culture and sensitivity. This was inoculated in thioglycollate broth and 
incubated for 24 hours at 37o C. After 24 hours the broth was examined primarily for the evidence of growth of the 
bacteria by direct gram stain smear. Then the sample was swabbed on the antibiotic disc with the sterile cotton swab as per 
Clinical and Laboratory Standards Institute (CLSI) standard guideline. Results: A total of 36 tracheostomies were 
performed during the period of this study. There were 29 (80.55%) males with a male: Female ratio of 4.14:1. The age of 
the patients ranged from 13 months to 78 years. The mean age was 58.08 ± 19.82 years. Patients with upper airway edema 
from trauma, burns, infection, or anaphylaxis (30.55%) followed by polytrauma and head injury who underwent 
tracheostomy (19.44%), congenital CNS malformation or disorders (16.66%) and supraglottic or glottic pathologic 
condition (eg, infection, neoplasm, bilateral vocal cord paralysis (13.88%). Thirty three out of 31 (86.11%) tracheal 
suction catheter tip cultures yielded a positive result on Day 7 or more. With respect to the identity of the bacteria studied 
in these positive cultures, they were mainly Acinetobacter baumanni (27.78%), Klebsiella pneumoniae (22.22%), Ps. 
Aeruginosa (19.44%), Methicillin-resistant Staphylococcus aureus (MRSA) (11.11%) and Acinetobacter/ Pr. Mirabilis/ 
Candida albicans (8.33% each). Conclusion: This study is a qualitative assessment of the tracheal flora and its antibiotic 
sensitivity patterns in patients with short term tracheostomies. The present study demonstrates that tracheostomy is 
independently associated with lower respiratory colonization which subsequently progresses to lower respiratory tract 
infection. 
Keywords: Endotracheal tube aspirates, tracheostomy, culture and sensitivity, gram negative and gram positive 
bacteria  
Introduction 
 
Tracheostomy is an operative procedure that 
creates a surgical airway in the cervical trachea[1,2]. It 
is most often performed in patients who have had  
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 difficulty weaning off a ventilator, followed by those 
who have suffered trauma or a catastrophic neurologic 
insult[3]. 
Infectious and neoplastic processes are less common in 
diseases that require a surgical airway. 
Initially all tracheostomy was carried out only 
to relieve the upper airway obstruction, gradually its 
indication became extensive and now it’s being 
increasingly used as temporary procedure for airway 
access especially for anesthetic purpose and artificial 
ventilation. Similarly the indication of long term or 
permanent tracheostomy as in cases of severe 
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respiratory distress, sleep apnoea syndrome and 
terminal malignant neoplasm are also increasing[4]. 
General indications for the placement of tracheostomy 
include acute respiratory failure with the expected need 
for prolonged mechanical ventilation, failure to wean 
from mechanical ventilation, upper airway obstruction, 
difficult airway, and copious secretions[5,6].The most 
common indications for tracheostomy are (1) acute 
respiratory failure and need for prolonged mechanical 
ventilation (representing two thirds of all cases) and (2) 
traumatic or catastrophic neurologic insult requiring 
airway, or mechanical ventilation or both. Upper 
airway obstruction is a less common indication for 
tracheostomy[7]. 
The normal trachea is protected from bacterial 
colonization, so that the trachea individuals harbors 
either no bacteria or oral flora in sparse numbers[8]. 
These defense mechanisms are partially bypassed 
following a tracheostomy and direct exposure of the 
lower airways to the pathogens may occur[9]. In case 
of intubated patients, colonization in the respiratory 
tract is most common[10].Again, mechanical 
ventilation is responsible 6 to 10 fold increase the risk 
of respiratory tract infections[11,12]. In this case 
tracheal colonization of bacterial isolates may be 
responsible for added or super infections and at the 
same time, increases the risk of mortality[13].So, the 
aim in our study was to detect the spectrum of bacterial 
isolates and their antibacterial sensitivity in AIMS, 
Dewas in last one year. 
Methods & patients 
We collected 36 endotracheal tube samples 
very aseptically. All the patients who were admitted in 
ICU of our hospital were on mechanical ventilation. 
All patients undergoing tracheostomy will be included 
except those omitted due to exclusion criteria. We 
collected the data from the enrolled patients in the form 
of:  demographic information, underlying illness, date 
of admission in our hospital, date of endotracheal tube 
intubation, date of sample collection and detail of 
antibiotic therapy prior to collection of samples. The 
collected specimen was kept in a sterile container and 
was sent immediately to microbiology department for 
culture and sensitivity. This was inoculated in 
thioglycollate broth and incubated for 24 hours at 37o 
C. After 24 hours the broth was examined primarily for 
the evidence of growth of the bacteria by direct gram 
stain smear. Smear was examined in the low power 
field (LPF) under oil immersion microscope (X100) for 
detection of squamous epithelial cells and 
polymorphonuclear nutrophils (PMN). The obtained 
organism was diluted in 2-3 ml of sterile normal saline. 
Tube change was done 2 to 11 days after tracheostomy. 
Tracheostomy tube was removed and new 
tracheostomy tube was inserted and the endotracheal 
suctioning was done with sterile suction catheter. In all 
patients included in the study, after a week of 
tracheostomy, a sterile suction catheter was introduced 
into the trachea and tracheal suctioning was done to 
clear the secretions. Using aseptic precautions, the tip 
of the suction catheter was cut and placed in a sterile 
container. The tip of the suction catheter was cut and 
kept in sterile container. The tip was sent for bacterial 
culture and sensitivity.  
Then the sample was swabbed on the 
antibiotic disc with the sterile cotton swab as per 
Clinical and Laboratory Standards Institute (CLSI) 
standard guideline[14].Antibiotic disc used from Gram 
negative bacilli were gentamicin, tobramycin, 
Netilmicin, amikacin, cefexime, ceftriaxone, 
ciprofloxacin, ofloxacin, levofloxacin, co-trimoxazole, 
chloramphenicol, tetracycline, tigicycline, piperacillin-
tazobactum, cefoperazone-sulbactam, ceftazidime, 
imipenem, meropenem, ertapenem, aztreonam, 
cefotaxime, polymyxin B, colistin. For Gram positive 
cases, amoxycillin, oxacilin, amoxycilin-clavauronic 
acid, piperacillin-tazobactum, cefoperazone-sulbactam, 
cefuroxime, ceftriaxone, cefexime, ceftazidime, 
azithromycin, erythromycin, ertapenem, meropenem, 
imipenem, gentamicin, tobramycin, Netilmicin, 
amikacin, ciprofloxacin, ofloxacin, levofloxacin, co-
trimoxazole, chloramphenicol, teicoplanin, tigicycline, 
clindamycin, vancomycin, tetracycline, linazolid, 
polymyxin B, colistin disc were used[13]. 
  Results on continuous measurements are 
presented on Mean± SD and results on categorical 
measurements are presented in Number (%). 
Significance is assessed at 5 % level of significance. 
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Results 
Table 1: Demographic and clinical characteristics of tracheotomised patients [n=36] 
Characteristics No. of the Patients  Percentage [%] 
Gender 
Male 
Female 
 
29 
7 
 
80.55 
19.45 
Mean Age [Yrs] 58.08 ± 19.82 - 
Age Groups [Yrs] 
<20  
21-40 
41-60 
>60 
 
2 
7 
11 
16 
 
5.55 
19.44 
30.55 
44.44 
Underlying condition 
• Neck trauma  
• Facial fractures 
• Cerebral palsy 
• Upper airway foreign body  
• Upper airway anomalies 
• Congenital CNS malformation or disorders 
• Supraglottic or glottic pathologic condition 
(eg, infection, neoplasm, bilateral vocal 
cord paralysis) 
• Cardiac anomaly 
• Upper airway edema from trauma, burns, 
infection, or anaphylaxis 
• Severe sleep apnea 
 
7 
4 
1 
2 
1 
 
6 
 
5 
 
 
1 
11 
                       1 
 
19.44 
11.11 
2.77 
5.55 
2.77 
 
16.66 
 
13.88 
 
 
2.77 
30.55 
                2.77 
Status of intubation before tracheostomy 
No 
Yes 
 
3 
33 
 
8.33 
91.67 
A total of 36 tracheostomies were performed 
during the period of this study. There were 29 
(80.55%) males with a male: Female ratio of 4.14:1. 
The age of the patients ranged from 13 months to 78 
years. The mean age was 58.08 ± 19.82 years. Majority 
of the patients who underwent tracheostomy was >60 
yrs (44.44%). Patients with upper airway edema from 
trauma, burns, infection, or anaphylaxis (30.55%) 
followed by polytrauma and head injury who 
underwent tracheostomy (19.44%), congenital CNS 
malformation or disorders (16.66%) and supraglottic or 
glottic pathologic condition (eg, infection, neoplasm, 
bilateral vocal cord paralysis (13.88%). Status of 
intubation before tracheostomy was positive in 33 
(91.67%) cases admitted.  
Table 2: Indication for tracheostomy [n=36] 
Indication for tracheostomy No. of the Patients  Percentage [%] 
Low GCS 14 38.89 
Prolonged ventilation  8 22.22 
Respiratory distress  4 11.11 
Respiratory Failure 
• Type 1 or Hypoxemic 
• Type 2 or Hypercapnic 
• Type III Respiratory Failure or Perioperative 
respiratory failure  
• Type IV Respiratory Failure or Shock 
 
3 
4 
 
2 
1 
 
8.33 
11.11 
 
5.56 
2.78 
 
Majority of the patients (38.89%) were for the tracheostomy is low GCS (47.5%) followed by respiratory 
failure (27.78%) and prolonged ventilation (22.22%) [Table 2].  
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Table 3: Number of days with endotracheal tube before tracheostomy procedure 
Number of days with ET tube before tracheostomy No. of the Patients  Percentage [%] 
Not intubated 3 8.33 
Intubated 33 91.67 
1-4 days 5 13.89 
4-7 days 18 50 
>7 days 10 27.78 
About 50% of the patients in this study were with endotracheal tube for the period of 4-7 days before the 
tracheostomy. About 27.78 of the patients in this study were with endotracheal tube for the period of >7 days before 
the tracheostomy [Table 3]. 
Table 4: Bacterial growth pattern in Day 0 Culture [n=36] 
Bacterial growth Frequency Percentage [%] 
No growth 33 91.67 
Growth 3 8.33 
Acinetobacter baumanni 1 2.78 
Klebsiella pneumoniae 1 2.78 
Ps. Aeruginosa  1 2.78 
There out of 36 (8.33%) tracheal suction 
catheter tip cultures yielded a positive result on Day 0. 
With respect to the identity of the bacteria studied in 
these positive cultures, they were Acinetobacter 
baumanni (2.78%), Klebsiella pneumoniae (2.78%) 
and Ps. Aeruginosa (2.78%) [Table 4]. 
Table 5: Bacterial growth pattern in Day 7 Culture [n=36] 
Bacterial growth Frequency Percentage [%] 
No growth 5 13.89 
Growth 31 86.11 
Acinetobacter baumanni 10 27.78 
Klebsiella pneumoniae 8 22.22 
Ps. Aeruginosa  7 19.44 
Staphylococcus  2 5.56 
NLFGNB  1 2.78 
Citrobacter  2 5.56 
Enterobacter  2 5.56 
Pr. Vulgaris  2 5.56 
Pr. Mirabilis  3 8.33 
E Coli (ESBL producer)  1 2.78 
Cedecea Lapages  1 2.78 
Methicillin-resistant Staphylococcus aureus (MRSA) 4 11.11 
Acinetobacter 3 8.33 
Mycobacterium  chelonae  1 2.78 
Mycobacterium fortuitum 0 0 
Candida albicans 3 8.33 
Thirty three out of 31 (86.11%) tracheal suction 
catheter tip cultures yielded a positive result on Day 7 
or more. With respect to the identity of the bacteria 
studied in these positive cultures, they were mainly 
Acinetobacter baumanni (27.78%), Klebsiella 
pneumoniae (22.22%), Ps. Aeruginosa (19.44%), 
Methicillin-resistant Staphylococcus aureus (MRSA) 
(11.11%) and Acinetobacter/ Pr. Mirabilis/ Candida 
albicans (8.33% each) [Table 5]. 
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Table 6: Antibiotic sensitivity pattern of the bacteria isolated during tube change 
Sensitivity pattern Number of patients [n=36] Percentage [%] 
Penicillin 3 8.33 
Amoxycllin 5 13.89 
Oxacilin 3 8.33 
Amoxycilin-Clavauronic Acid  26 72.22 
Piperacillin-Tazobactum 26 72.22 
Cefoperazone-Sulbactam 23 63.89 
Cefuroxime 9 25 
Ceftriaxone 10 27.78 
Cefexime 9 25 
Ceftazidime 14 38.89 
Azithromycin 18 50 
Erythromycin 11 30.56 
Ertapenem 16 44.44 
Meropenem 26 72.22 
Imipenem 13 36.11 
Gentamicin 11 30.56 
Tobramycin 15 41.67 
Netilmicin 7 19.44 
Amikacin 19 52.78 
Ciprofloxacin 5 13.89 
Ofloxacin 3 8.33 
Levofloxacin 11 30.56 
Co-Trimoxazole 9 25 
Chloramphenicol 13 36.11 
Teicoplanin 24 66.67 
Tigicycline 17 47.22 
Clindamycin 9 25 
Vancomycin 19 52.78 
Tetracycline 2 5.56 
Linazolid 26 72.22 
Polymyxin B 22 61.11 
Colistin 22 61.11 
In our study, incidences of prevalent bacteria 
were acinetobacter baumannii (27.78%), Klebsiella 
group (22.22%) pseudomonas aeruginosa (19.44%), 
staphylococcus (5.56%), E coli and enterobacter group 
(5.56%). So incidence of acinetobacter was highest 
followed by Klebsiella. Over all antibiotic sensitivity 
was observed highly to amoxycilin-clavauronic acid 
(72.22%), piperacillin-tazobactam (72.22%), 
meropenem (72.22%), linazolid (72.22%), teicoplanin 
(66.67%), cefoperazone-sulbactam (63.89%), 
polymyxin B and colistin (61.11%). Non ESBL and 
AMPC producer Klebsiella and AMPC producer 
Klebsiella sensitive to ertapenem, imipenem and 
meropenem (44.44%, 36.11% and 72.22% 
respectively), polymyxin B and colistin (61.11%). On 
the other hand ESBL and AMPC producing Klebsiella 
were sensitive to ertapenem, imipenem and meropenem 
(86.11% to 100%) and carbapenemase producing 
Klebsiella were highly sensitive to polymyxin B and 
colistin (75%). Citrobacter were sensitive to 
chloramphenicol (60%) and polymyxin B and colistin 
(61.11%) and enterobacter sensitive to polymyxin B 
(36.11%) and colistin (68.75%) only. Acinetobacter 
baumannii (both MBL and non MBL producer), 
pseudomonas aeruginosa (MBL inhibitor) were 
significantly sensitive to polymyxin B and colistin 
(80.55 %, 80.55 and 86.11% respectively) [Table 6]. 
Discussion 
Aspiration of secretions into the lower part of 
the respiratory tract is a risk factor for pneumonia. [15-
18] Many potential pathogens endogenous to the 
normal oral flora, such as Staphylococcus aureus and 
various species of Streptococcus, may be introduced 
into the lower part of the respiratory tract during 
intubation[19].  Once a patient is intubated, 
microaspiration of secretions from above the cuff of 
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the endotracheal tube may occur. Oral secretions can 
be colonized with endogenous and/or exogenous 
pathogens. Exogenous pathogens, such as gram-
negative bacteria and antibiotic-resistant organisms, 
can be introduced into a patient’s mouth secondary to 
lack of hand washing and through devices such as oral 
suctioning equipment. Some organisms, such as 
Pseudomonas, can be transmitted either endogenously 
or exogenously[19]. 
Intubation process itself facilitates the entry of 
bacteria from upper airway into the lower respiratory 
tract and endotracheal tube further facilitates pooling 
and leakage of contaminated secretions around the 
endotracheal cuff. The use of endotracheal & 
tracheostomy tubes equipped with high volume cuffs 
and inflation pressure lower than the intra capillary 
pressure (<30mmHg/<40 cmH2O) has been proposed 
to prevent mucosal damage resulting from the pressure 
exerted by the tube cuff. However narrow longitudinal 
folds form on the surface of high volume cuff as well 
as between the cuff and tracheal wall permitting 
leakage past the cuff. These folds may promote 
aspiration of regurgitated gastric fluid[20, 21 ] 
In our study total of 36 tracheostomies were 
performed during the period of this study. There were 
29 (80.55%) males with a male: Female ratio of 4.14:1. 
The age of the patients ranged from 13 months to 78 
years. The mean age was 58.08 ± 19.82 years. Saha AK 
et al13 study revealed incidence of positivity in males 
was 69.17%, which was significant as compared to 
females (26.25%, p=0.00). In the present study 
majority of the patients (38.89%) were for the 
tracheostomy is low GCS (47.5%) followed by 
respiratory failure (27.78%) and prolonged ventilation 
(22.22%). 
Study by M Hemanth Rao et al study showed 
that patients with cerebrovascular accidents (CNS) 
constituted highest percentage (45%) followed by 
patients with Polytrauma and head injury 
(22.5%)[22].Respiratory group included 6 patients 
(15%), of which 3 patients had COPD, 2 patients had 
cor pulmonale and 1 patient had edema of the upper 
aero digestive tract. About 38 patients (95%) were 
intubated before tracheostomy and 2 patients were not 
intubated before tracheostomy. The most common 
indication for the tracheostomy is Low GCS (47.5%) 
followed by prolonged ventilation (27.5%). The third 
most common indication for the tracheostomy is 
respiratory failure (15%). 
In our study about 50% of the patients in this 
study were with endotracheal tube for the period of 4-7 
days before the tracheostomy. About 27.78 of the 
patients in this study were with endotracheal tube for 
the period of >7 days before the tracheostomy. Study 
by M Hemanth Rao et al study revealed that first 
tracheostomy tube change was done between 2 to 9 
days (4.10 ±1.87)[22].Most of the patients underwent 
first tracheostomy tube change between 3 to 8 days 
(80%).  
In our study, incidences of prevalent bacteria 
were acinetobacter baumannii (27.78%), Klebsiella 
group (22.22%) pseudomonas aeruginosa (19.44%), 
staphylococcus (5.56%), E coli and enterobacter group 
(5.56%). So incidence of acinetobacter was highest 
followed by Klebsiella. Study by Ashis Kumar Saha et 
al13 revealed the incidences of prevalent bacteria were 
acinetobacter baumannii (33.33%), Klebsiella group 
(31.73%), pseudomonas aeruginosa (18.72%), 
staphylococcus (2.05%), E coli and enterobacter group 
(3.65%). So incidence of acinetobacter was highest 
followed by Klebsiella. Kamath PM et al study noted 
Gram Negative Bacteria (GNB) were cultured more 
frequently in the samples studied[23]. Pseudomonas 
aeruginosa being the most commonly isolated bacteria. 
Many other similar studies on tracheostomy have 
shown that GNB are the most common pathogens 
causing nosocomial pneumonia[24,25].In a recent 
study by Pignattiet al[14], in the microbiological 
analysis performed on tracheal aspirates, Pseudomonas 
aeruginosa was most commonly identified. 
Guimbellotet al also noted increased development of 
gram negative bacterial infection in children 
undergoing tracheostomy[26]. Sakurai et al studied 15 
patients with long term tracheostomies and noted 
persistent colonization with Pseudomonas in them [27]. 
Harlid R et al revealed patients were 
colonized with one or more potential pathogens at the 
stomal site and in the trachea in 95% and 83%, 
respectively, of all sampling occasions [25]. 
Staphylococcus aureus, gram-negative enteric bacteria 
(GNEB), and Pseudomonas aeruginosa were the most 
common colonizing bacteria at these sites. Only 18 of 
39 (46%) patients were treated with antibiotics because 
of RTIs on a total of 30 occasions during the study 
year.  
Present study showed overall antibiotic 
sensitivity was observed highly to amoxycilin-
clavauronic acid (72.22%), piperacillin-tazobactam 
(72.22%), meropenem (72.22%), linazolid (72.22%), 
teicoplanin (66.67%), cefoperazone-sulbactam 
(63.89%), polymyxin B and colistin (61.11%). Non 
ESBL and AMPC producer Klebsiella and AMPC 
producer Klebsiella sensitive to ertapenem, imipenem 
and meropenem (44.44%, 36.11% and 72.22% 
respectively), polymyxin B and colistin (61.11%). On 
the other hand ESBL and AMPC producing Klebsiella 
were sensitive to ertapenem, imipenem and meropenem 
(86.11% to 100%) and carbapenemase producing 
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Klebsiella were highly sensitive to polymyxin B and 
colistin (75%). Citrobacter were sensitive to 
chloramphenicol (60%) and polymyxin B and colistin 
(61.11%) and enterobacter sensitive to polymyxin B 
(36.11%) and colistin (68.75%) only. Acinetobacter 
baumannii (both MBL and non MBL producer), 
pseudomonas aeruginosa (MBL inhibitor) were 
significantly sensitive to polymyxin B and colistin 
(80.55 %, 80.55 and 86.11% respectively). 
Study by Ashis Kumar Saha et al revealed that 
ESBL producing Klebsiella pneumonie was highly 
sensitive to piperacillin-tazobactam (52.63%), 
polymyxin B and colistin (90.69%)[13]. Non ESBL 
and AMPC producer Klebsiella and AMPC producer 
Klebsiella sensitive to ertapenem, imipenem and 
meropenem (55.81%, 65.11% and 56.97% 
respectively), polymyxin B and colistin (90.69%). On 
the other hand ESBL and AMPC producing Klebsiella 
were sensitive to ertapenem, imipenem and meropenem 
(90.90% to 100%) and carbapenemase producing 
Klebsiella were highly sensitive to polymyxin B and 
colistin (95.65%). Citrobacter were highly sensitive to 
chloramphenicol (60%) and polymyxin B and colistin 
(90%) and enterobacter sensitive to polymyxin B 
(62.5%) and colistin (68.75%) only. Again, gram 
positive bacteria staphylococcus were highly sensitive 
to vancomycin, teicoplanin and linazolid (99.99%), 
chloramphenicol (88.88%) followed by tetracycline 
and tigicycline (55.55%). 
 
Conclusion 
 
The data in the current study provides further 
evidence of airway colonization with potentially 
pathogenic bacteria post-tracheostomy. This study is a 
qualitative assessment of the tracheal flora and its 
antibiotic sensitivity patterns in patients with short term 
tracheostomies. The present study demonstrates that 
tracheostomy is independently associated with lower 
respiratory colonization which subsequently progresses 
to lower respiratory tract infection. Patients on 
tracheostomy therapy are at high risk for contracting 
lower respiratory tract infections which is 
predominantly due to GNB like pseudomonas 
aeruginosa, klebsiella pneumonia and acenitobacter 
spps. Bacteria like Acenitobacter spps were found to be 
persistently present in previously intubated patients and 
who were cared for in an ICU. Factors causing 
colonisation are many, but it is important for us as 
clinicians to identify this emergence early and treat the 
patients promptly.  
There are several limitations in our study. This 
was a single center prospective study with flexible 
inclusion criteria for possible bacterial pneumonia 
episodes to prevent overlooking possible bacterial 
infections. Our sample size was not sufficiently large 
due to the relatively limited number of patients with 
tracheostomy in limited period of study, and it only 
reflects experiences from a single medical center. 
However, the characteristics of respiratory tract 
infections in patients with tracheostomy can still be 
deduced from our data. 
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